Skip to main content
. 2019 Jul-Sep;18(3):232–237. doi: 10.4103/wjnm.WJNM_59_18

Figure 3.

Figure 3

Initial treatment for this patient's prostate cancer was radical prostatectomy and radiotherapy. The prostate-specific antigen increased to 1.25 μg/L posttreatment. Prostate-specific membrane antigen positron emission tomography demonstrated avid lymph nodes in pelvis